Patents by Inventor Feijiao GE

Feijiao GE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT WITH ANTI-TIGIT ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS
    Publication number: 20210395366
    Abstract: The present invention relates to the treatment of esophageal cancer, e.g., esophageal squamous cell carcinoma (ESCC) (e.g., advanced ESCC (e.g., unresectable, locally advanced, recurrent, and/or metastatic ESCC)). More specifically, the invention pertains to the treatment of patients having esophageal cancer by administering a combination of an anti-T-cell immunoreceptor with Ig and ITIM domains (TIGIT) antagonist antibody and a programmed death-1 (PD-1) axis binding antagonist.
    Type: Application
    Filed: January 26, 2021
    Publication date: December 23, 2021
    Inventors: Shi LI, Meghna Das Thakur HARRIS, Yifan WANG, Edward Namserk CHA, Feijiao GE